Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Lawrie

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Circulation Research|December 7, 2019
Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF SignalingSimon Tual-Chalot, Maria Garcia-Collado, Rachael E Redgrave, et al.
Nature Cardiovascular Research|August 28, 2024
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertensionOlivier Boucherat, Tetsuro Yokokawa, Vinod Krishna, et al.
Circulation Research|August 29, 2009
S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4Edda Spiekerkoetter, Christophe Guignabert, Vinicio de Jesus Perez, et al.
Pulmonary Circulation|December 21, 2017
Selective improvement of pulmonary arterial hypertension with a dual ET<sub>A</sub>/ET<sub>B</sub> receptors antagonist in the apolipoprotein E<sup>-/-</sup> model of PAH and atherosclerosisLewis Renshall, Nadine Arnold, Laura West, et al.
BMC Pulmonary Medicine|March 4, 2018
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertensionMario Boehm, Nadine Arnold, Adam Braithwaite, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2025
Clustering Pulmonary Hypertension Patients Using the Plasma ProteomeAthénaïs Boucly, Shanshan Song, Merve Keles, et al.
BMC Pulmonary Medicine|July 20, 2022
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertensionMario Boehm, Nadine Arnold, Adam Braithwaite, et al.
NPJ Cardiovascular Health|March 26, 2026
Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertensionJuan A Delgado-SanMartin, Merve Keles, Niamh Errington, et al.
European Heart Journal. Cardiovascular Imaging|January 31, 2020
A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosisAndrew J Swift, Haiping Lu, Johanna Uthoff, et al.
Pulmonary Circulation|December 19, 2024
The hepcidin-ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cellsTheo Issitt, Quezia K Toe, Sofia L Pedersen, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Circulation Research|December 7, 2019
Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF SignalingSimon Tual-Chalot, Maria Garcia-Collado, Rachael E Redgrave, et al.
Nature Cardiovascular Research|August 28, 2024
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertensionOlivier Boucherat, Tetsuro Yokokawa, Vinod Krishna, et al.
Circulation Research|August 29, 2009
S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4Edda Spiekerkoetter, Christophe Guignabert, Vinicio de Jesus Perez, et al.
Pulmonary Circulation|December 21, 2017
Selective improvement of pulmonary arterial hypertension with a dual ET<sub>A</sub>/ET<sub>B</sub> receptors antagonist in the apolipoprotein E<sup>-/-</sup> model of PAH and atherosclerosisLewis Renshall, Nadine Arnold, Laura West, et al.
BMC Pulmonary Medicine|March 4, 2018
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertensionMario Boehm, Nadine Arnold, Adam Braithwaite, et al.
American Journal of Respiratory and Critical Care Medicine|May 9, 2025
Clustering Pulmonary Hypertension Patients Using the Plasma ProteomeAthénaïs Boucly, Shanshan Song, Merve Keles, et al.
BMC Pulmonary Medicine|July 20, 2022
Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertensionMario Boehm, Nadine Arnold, Adam Braithwaite, et al.
NPJ Cardiovascular Health|March 26, 2026
Assessing the feasibility of using smartphone data to identify risk of idiopathic pulmonary arterial hypertensionJuan A Delgado-SanMartin, Merve Keles, Niamh Errington, et al.
European Heart Journal. Cardiovascular Imaging|January 31, 2020
A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosisAndrew J Swift, Haiping Lu, Johanna Uthoff, et al.
Pulmonary Circulation|December 19, 2024
The hepcidin-ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cellsTheo Issitt, Quezia K Toe, Sofia L Pedersen, et al.
Pageof 14